▶ 調査レポート

マイクロRNAの世界市場

• 英文タイトル:Global Market Study on MicroRNA: PCR Based Arrays Largest Segment by Assay Type

Persistence Market Researchが調査・発行した産業分析レポートです。マイクロRNAの世界市場 / Global Market Study on MicroRNA: PCR Based Arrays Largest Segment by Assay Type / B-PMR-194資料のイメージです。• レポートコード:B-PMR-194
• 出版社/出版日:Persistence Market Research / 2017年10月11日
• レポート形態:英文、PDF、273ページ
• 納品方法:Eメール(受注後2営業日)
• 産業分類:医療・バイオ
• 販売価格(消費税別)
  Individual(1名、印刷不可)¥519,400 (USD4,900)▷ お問い合わせ
  Multi User(5名)¥805,600 (USD7,600)▷ お問い合わせ
  Corporate User¥1,123,600 (USD10,600)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当調査レポートでは、マイクロRNAの世界市場について調査・分析し、関連企業情報、産業分析、マイクロRNAの世界市場規模、市場動向、セグメント別市場分析、地域別市場規模(欧州、アメリカ、アジアなど)、市場予測データを含め、以下の構成でお届けいたします。

Persistence Market Research in its newly published report titled “MicroRNA Market: Global Industry Analysis (2012-2016) and Forecast (2017-2025),” provides forecast and analysis of the global microRNA market on the global and regional levels. Through an extensive research, our analysts have studied how the different market dynamics are likely to impact the current and future scenario of the global microRNA market, thereby providing useful insights to market players to plan their differentiating strategies, capable of evolving with the changing market landscape. We have analyzed the key trends, drivers, restraints and opportunities while studying this report. Impact analysis of key growth drivers and restraints based on the weighted average model are included in the report to better equip and arm clients with crystal-clear and decision-making insights.
The report has indicated the segment wise definition of the market along with its overall scenario in the assessment period. The publication focuses on to identify opportunities in the market and present updates and insights, pertaining to the various segments of the global microRNA market. While researching this report, market splits have been deduced from a survey and primary research. This report provides historical data of 2012-2016 along with forecast from 2017 to 2025 in terms of revenue (US$ Dollar).

Report Structure

The global microRNA market report begins with the definition of the market and relevance and impact of forecast factors used to estimate the global microRNA market growth. It is followed by an overview of market dynamics of the global microRNA market, which includes Persistence Market Research’s analysis of key trends, drivers, restraints and opportunities that are influencing the development of the global microRNA market. Impact analysis of key growth drivers and restraints based on the weighted average model has been included at a regional level in the global market report after detailed analysis of individual regions to better equip readers with meaningful insights on ongoing developments in the global microRNA market.

In the final section of the report on the global microRNA market, detailed profiles of life sciences laboratories are included to evaluate their long- and short-term strategies, key offerings, SWOT analysis, and recent developments in the global microRNA market.

Market Segmentation

Assay Type

PCR-based Assay
miRNA Arrays
Next Generation Sequencing (NGS)
Immunoassay
Fluorescent Assays
Colorimetric Assays
Chemiluminescent Assays
Application

Clinical Diagnostics
Research
End User

Academic and Research Institutes
Biopharmaceutical Companies
Contract Research Organizations
Diagnostic Centers
Region

North America
Latin America
Europe
Asia Pacific
Middle East & Africa
Research Methodology

The forecast presented in this report assesses the total revenue of the global microRNA market. When developing the market forecast, the starting point involves sizing the current market, which forms the basis for the forecast of how the market is anticipated to take shape in the near future. Given the characteristics of the market, the analysts have triangulated the outcome on the basis of analysis based on supply and demand sides. The report also takes into consideration year-on-year growth to understand the predictability of the market and to identify the right opportunities across the global microRNA market. As previously highlighted, the global market for microRNA is split into various categories. All these segments have been analyzed in terms of basis point share to understand segmental contribution to overall market growth. This detailed level of information is important to identify various key trends in the global microRNA market.

Macro-economic indicators such as life science reagents and tools market outlook, expenditure on life science research, Gross Domestic Product and others has been considered to arrive at the indicated market numbers. Bottom-up approach has been used to assess market numbers for each product category while the top-down approach has been used to counter-validate the estimated market numbers. Historical trend has been analyzed to track data.

レポート目次

1. Executive Summary
1.1. Market Overview
1.2. Market Analysis
1.3. Wheel of Fortune

2. Market Introduction
2.1. Market Definition
2.2. Market Taxonomy

3. MicroRNA Market View Point
3.1. Macro-Economic Factors
3.2. Opportunities
3.3. Technology Assessment Analysis

4. North America MicroRNA Market Analysis 2012–2016 and Forecast 2017–2025
4.1. Introduction
4.2. Regional Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Trends
4.3. Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2016
4.3.1. U.S.
4.3.2. Canada
4.4. Market Size (US$ Mn) Forecast By Country, 2017–2025
4.4.1. U.S.
4.4.2. Canada
4.5. Historical Market Size (US$ Mn) Trend Analysis By Assay Type , 2012–2016
4.5.1. Immunoassay
4.5.1.1. Fluorescent Assays
4.5.1.2. Colorimetric Assays
4.5.1.3. Chemiluminescent Assays
4.5.2. Next Generation Sequencing (NGS)
4.5.3. miRNA Arrays
4.5.4. PCR-based Assay
4.6. Market Size (US$ Mn) Forecast By Assay Type, 2017–2025
4.6.1. Immunoassay
4.6.1.1. Fluorescent Assays
4.6.1.2. Colorimetric Assays
4.6.1.3. Chemiluminescent Assays
4.6.2. Next Generation Sequencing (NGS)
4.6.3. miRNA Arrays
4.6.4. PCR-based Assay
4.7. Historical Market Size (US$ Mn) Trend Analysis By Application , 2012–2016
4.7.1. Research
4.7.2. Clinical Diagnostics
4.8. Market Size (US$ Mn) Forecast By Application, 2017–2025
4.8.1. Research
4.8.2. Clinical Diagnostics
4.9. Historical Market Size (US$ Mn) Trend Analysis By End User , 2012–2016
4.9.1. Academic and Research Institutes
4.9.2. Biopharmaceutical Companies
4.9.3. Contract Research Organizations
4.9.4. Diagnostic Centers
4.10. Market Size (US$ Mn) Forecast By End User , 2017–2025
4.10.1. Academic and Research Institutes
4.10.2. Biopharmaceutical Companies
4.10.3. Contract Research Organizations
4.10.4. Diagnostic Centers
4.11. Drivers and Restraints: Impact Analysis
4.12. Market Attractiveness Analysis
4.12.1. By Country
4.12.2. By Assay Type
4.12.3. By Application
4.12.4. By End User
4.13. North America MicroRNA Key Participants Market Presence (Intensity Map)

5. Latin America MicroRNA Market Analysis 2012–2016 and Forecast 2017–2025
5.1. Introduction
5.2. Regional Market Dynamics
5.2.1. Drivers
5.2.2. Restraints
5.2.3. Trends
5.3. Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2016
5.3.1. Brazil
5.3.2. Mexico
5.3.3. Rest of Latin America
5.4. Market Size (US$ Mn) Forecast By Country, 2017–2025
5.4.1. Brazil
5.4.2. Mexico
5.4.3. Rest of Latin America
5.5. Historical Market Size (US$ Mn) Trend Analysis By Assay Type , 2012–2016
5.5.1. Immunoassay
5.5.1.1. Fluorescent Assays
5.5.1.2. Colorimetric Assays
5.5.1.3. Chemiluminescent Assays
5.5.2. Next Generation Sequencing (NGS)
5.5.3. miRNA Arrays
5.5.4. PCR-based Assay
5.6. Market Size (US$ Mn) Forecast By Assay Type, 2017–2025
5.6.1. Immunoassay
5.6.1.1. Fluorescent Assays
5.6.1.2. Colorimetric Assays
5.6.1.3. Chemiluminescent Assays
5.6.2. Next Generation Sequencing (NGS)
5.6.3. miRNA Arrays
5.6.4. PCR-based Assay
5.7. Historical Market Size (US$ Mn) Trend Analysis By Application , 2012–2016
5.7.1. Research
5.7.2. Clinical Diagnostics
5.8. Market Size (US$ Mn) Forecast By Application, 2017–2025
5.8.1. Research
5.8.2. Clinical Diagnostics
5.9. Historical Market Size (US$ Mn) Trend Analysis By End User , 2012–2016
5.9.1. Academic and Research Institutes
5.9.2. Biopharmaceutical Companies
5.9.3. Contract Research Organizations
5.9.4. Diagnostic Centers
5.10. Market Size (US$ Mn) Forecast By End User , 2017–2025
5.10.1. Academic and Research Institutes
5.10.2. Biopharmaceutical Companies
5.10.3. Contract Research Organizations
5.10.4. Diagnostic Centers
5.11. Drivers and Restraints: Impact Analysis
5.12. Market Attractiveness Analysis
5.12.1. By Country
5.12.2. By Assay Type
5.12.3. By Application
5.12.4. By End User
5.13. Latin America MicroRNA Key Participants Market Presence (Intensity Map)

6. Europe MicroRNA Market Analysis 2012–2016 and Forecast 2017–2025
6.1. Introduction
6.2. Regional Market Dynamics
6.2.1. Drivers
6.2.2. Restraints
6.2.3. Trends
6.3. Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2016
6.3.1. Germany
6.3.2. UK
6.3.3. France
6.3.4. Italy
6.3.5. Spain
6.3.6. Russia
6.3.7. Rest of Europe
6.4. Market Size (US$ Mn) Forecast By Country, 2017–2025
6.4.1. Germany
6.4.2. UK
6.4.3. France
6.4.4. Italy
6.4.5. Spain
6.4.6. Russia
6.4.7. Rest of Europe
6.5. Historical Market Size (US$ Mn) Trend Analysis By Assay Type , 2012–2016
6.5.1. Immunoassay
6.5.1.1. Fluorescent Assays
6.5.1.2. Colorimetric Assays
6.5.1.3. Chemiluminescent Assays
6.5.2. Next Generation Sequencing (NGS)
6.5.3. miRNA Arrays
6.5.4. PCR-based Assay
6.6. Market Size (US$ Mn) Forecast By Assay Type, 2017–2025
6.6.1. Immunoassay
6.6.1.1. Fluorescent Assays
6.6.1.2. Colorimetric Assays
6.6.1.3. Chemiluminescent Assays
6.6.2. Next Generation Sequencing (NGS)
6.6.3. miRNA Arrays
6.6.4. PCR-based Assay
6.7. Historical Market Size (US$ Mn) Trend Analysis By Application , 2012–2016
6.7.1. Research
6.7.2. Clinical Diagnostics
6.8. Market Size (US$ Mn) Forecast By Application, 2017–2025
6.8.1. Research
6.8.2. Clinical Diagnostics
6.9. Historical Market Size (US$ Mn) Trend Analysis By End User , 2012–2016
6.9.1. Academic and Research Institutes
6.9.2. Biopharmaceutical Companies
6.9.3. Contract Research Organizations
6.9.4. Diagnostic Centers
6.10. Market Size (US$ Mn) Forecast By End User , 2017–2025
6.10.1. Academic and Research Institutes
6.10.2. Biopharmaceutical Companies
6.10.3. Contract Research Organizations
6.10.4. Diagnostic Centers
6.11. Drivers and Restraints: Impact Analysis
6.12. Market Attractiveness Analysis
6.12.1. By Country
6.12.2. By Assay Type
6.12.3. By Application
6.12.4. By End User
6.13. Europe MicroRNA Key Participants Market Presence (Intensity Map)

7. Asia Pacific MicroRNA Market Analysis 2012–2016 and Forecast 2017–2025
7.1. Introduction
7.2. Regional Market Dynamics
7.2.1. Drivers
7.2.2. Restraints
7.2.3. Trends
7.3. Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2016
7.3.1. China
7.3.2. India
7.3.3. Japan
7.3.4. Australia and New Zealand
7.3.5. Rest of Asia Pacific
7.4. Market Size (US$ Mn) Forecast By Country, 2017–2025
7.4.1. China
7.4.2. India
7.4.3. Japan
7.4.4. Australia and New Zealand
7.4.5. Rest of Asia Pacific
7.5. Historical Market Size (US$ Mn) Trend Analysis By Assay Type , 2012–2016
7.5.1. Immunoassay
7.5.1.1. Fluorescent Assays
7.5.1.2. Colorimetric Assays
7.5.1.3. Chemiluminescent Assays
7.5.2. Next Generation Sequencing (NGS)
7.5.3. miRNA Arrays
7.5.4. PCR-based Assay
7.6. Market Size (US$ Mn) Forecast By Assay Type, 2017–2025
7.6.1. Immunoassay
7.6.1.1. Fluorescent Assays
7.6.1.2. Colorimetric Assays
7.6.1.3. Chemiluminescent Assays
7.6.2. Next Generation Sequencing (NGS)
7.6.3. miRNA Arrays
7.6.4. PCR-based Assay
7.7. Historical Market Size (US$ Mn) Trend Analysis By Application , 2012–2016
7.7.1. Research
7.7.2. Clinical Diagnostics
7.8. Market Size (US$ Mn) Forecast By Application, 2017–2025
7.8.1. Research
7.8.2. Clinical Diagnostics
7.9. Historical Market Size (US$ Mn) Trend Analysis By End User , 2012–2016
7.9.1. Academic and Research Institutes
7.9.2. Biopharmaceutical Companies
7.9.3. Contract Research Organizations
7.9.4. Diagnostic Centers
7.10. Market Size (US$ Mn) Forecast By End User , 2017–2025
7.10.1. Academic and Research Institutes
7.10.2. Biopharmaceutical Companies
7.10.3. Contract Research Organizations
7.10.4. Diagnostic Centers
7.11. Drivers and Restraints: Impact Analysis
7.12. Market Attractiveness Analysis
7.12.1. By Country
7.12.2. By Assay Type
7.12.3. By Application
7.12.4. By End User
7.13. Asia Pacific MicroRNA Key Participants Market Presence (Intensity Map)

8. Middle East & Africa MicroRNA Market Analysis 2012–2016 and Forecast 2017–2025
8.1. Introduction
8.2. Regional Market Dynamics
8.2.1. Drivers
8.2.2. Restraints
8.2.3. Trends
8.3. Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2016
8.3.1. GCC Countries
8.3.2. South Africa
8.3.3. Rest of MEA
8.4. Market Size (US$ Mn) Forecast By Country, 2017–2025
8.4.1. GCC Countries
8.4.2. South Africa
8.4.3. Rest of MEA
8.5. Historical Market Size (US$ Mn) Trend Analysis By Assay Type , 2012–2016
8.5.1. Immunoassay
8.5.1.1. Fluorescent Assays
8.5.1.2. Colorimetric Assays
8.5.1.3. Chemiluminescent Assays
8.5.2. Next Generation Sequencing (NGS)
8.5.3. miRNA Arrays
8.5.4. PCR-based Assay
8.6. Market Size (US$ Mn) Forecast By Assay Type, 2017–2025
8.6.1. Immunoassay
8.6.1.1. Fluorescent Assays
8.6.1.2. Colorimetric Assays
8.6.1.3. Chemiluminescent Assays
8.6.2. Next Generation Sequencing (NGS)
8.6.3. miRNA Arrays
8.6.4. PCR-based Assay
8.7. Historical Market Size (US$ Mn) Trend Analysis By Application , 2012–2016
8.7.1. Research
8.7.2. Clinical Diagnostics
8.8. Market Size (US$ Mn) Forecast By Application, 2017–2025
8.8.1. Research
8.8.2. Clinical Diagnostics
8.9. Historical Market Size (US$ Mn) Trend Analysis By End User , 2012–2016
8.9.1. Academic and Research Institutes
8.9.2. Biopharmaceutical Companies
8.9.3. Contract Research Organizations
8.9.4. Diagnostic Centers
8.10. Market Size (US$ Mn) Forecast By End User , 2017–2025
8.10.1. Academic and Research Institutes
8.10.2. Biopharmaceutical Companies
8.10.3. Contract Research Organizations
8.10.4. Diagnostic Centers
8.11. Drivers and Restraints: Impact Analysis
8.12. Market Attractiveness Analysis
8.12.1. By Country
8.12.2. By Assay Type
8.12.3. By Application
8.12.4. By End User
8.13. Middle East & Africa MicroRNA Key Participants Market Presence (Intensity Map)

9. Forecast Factors: Relevance and Impact

10. Forecast Assumptions

11. Competition Landscape
11.1. Competition Dashboard
11.2. Company Profiles (Details – Overview, Financials, Strategy, SWOT, Recent Developments)
11.2.1. Illumina, Inc.
11.2.2. F. Hoffmann-La Roche Ltd
11.2.3. Agilent Technologies
11.2.4. Bio-Rad Laboratories Inc.
11.2.5. Sigma Aldrich Corp.
11.2.6. Qiagen N.V
11.2.7. Thermo Fisher Scientific, Inc.
11.2.8. HTG Molecular Diagnostics, Inc.
11.2.9. Bioline GmbH (A Meridian Life Science Company)
11.2.10. Rosetta Genomics Ltd.
11.2.11. Dharmacon, a Horizon Discovery Group Co.
11.2.12. BioVendor — Laboratorní medicína a.s.
11.2.13. Miltenyi Biotec
11.2.14. Kaneka Corporation (Eurogentec)
11.2.15. Abcam Plc
11.2.16. GeneCopoeia, Inc.
11.2.17. Promega Corporation
11.2.18. New England Biolabs, Inc.
11.2.19. NanoString Technologies, Inc.
11.2.20. System Biosciences LLC

12. Global MicroRNA Market Analysis 2012–2016 and Forecast 2017–2025, By Region
12.1. Introduction
12.2. Historical Market Size (US$ Mn) Trend Analysis By Region, 2012–2016
12.2.1. North America
12.2.2. Latin America
12.2.3. Europe
12.2.4. Asia Pacific
12.2.5. Middle East & Africa
12.3. Market Size (US$ Mn) Forecast By Region, 2017–2025
12.3.1. North America
12.3.2. Latin America
12.3.3. Europe
12.3.4. Asia Pacific
12.3.5. Middle East & Africa
12.4. Market Attractiveness Analysis By Region

13. Global MicroRNA Market Analysis 2012–2016 and Forecast 2017–2025, By Assay Type
13.1. Introduction
13.2. Historical Market Size (US$ Mn) Trend Analysis By Assay Type , 2012–2016
13.2.1. Immunoassay
13.2.1.1. Fluorescent Assays
13.2.1.2. Colorimetric Assays
13.2.1.3. Chemiluminescent Assays
13.2.2. Next Generation Sequencing (NGS)
13.2.3. miRNA Arrays
13.2.4. PCR-based Assay
13.3. Market Size (US$ Mn) and Forecast By Assay Type, 2017–2025
13.3.1. Immunoassay
13.3.1.1. Fluorescent Assays
13.3.1.2. Colorimetric Assays
13.3.1.3. Chemiluminescent Assays
13.3.2. Next Generation Sequencing (NGS)
13.3.3. miRNA Arrays
13.3.4. PCR-based Assay
13.4. Market Attractiveness Analysis By Assay Type

14. Global MicroRNA Market Analysis 2012–2016 and Forecast 2017–2025, By Application
14.1. Introduction
14.2. Historical Market Size (US$ Mn) Trend Analysis By Application , 2012–2016
14.2.1. Research
14.2.2. Clinical Diagnostics
14.3. Market Size (US$ Mn) and Forecast By Application, 2017–2025
14.3.1. Research
14.3.2. Clinical Diagnostics
14.4. Market Attractiveness Analysis By Application

15. Global MicroRNA Market Analysis 2012–2016 and Forecast 2017–2025, By End User
15.1. Introduction
15.2. Historical Market Size (US$ Mn) Trend Analysis By End User, 2012–2016
15.2.1. Academic and Research Institutes
15.2.2. Biopharmaceutical Companies
15.2.3. Contract Research Organizations
15.2.4. Diagnostic Centers
15.3. Market Size (US$ Mn) Forecast By End User, 2017–2025
15.3.1. Academic and Research Institutes
15.3.2. Biopharmaceutical Companies
15.3.3. Contract Research Organizations
15.3.4. Diagnostic Centers
15.4. Market Attractiveness Analysis By End User

16. Global MicroRNA Market Analysis 2012–2016 and Forecast 2017–2025
16.1. Market Size and Y-o-Y Growth
16.2. Absolute $ Opportunity

List of Tables

Table 01: North America MicroRNA Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2025, By Country
Table 02: North America MicroRNA Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2025, By Assay Type
Table 03: North America MicroRNA Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2025, By Applications
Table 04: North America MicroRNA Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2025, By End User
Table 05: Latin America MicroRNA Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2025, By Country
Table 06: Latin America MicroRNA Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2025, By Assay Type
Table 07: Latin America MicroRNA Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2025, By Applications
Table 08: Latin America MicroRNA Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2025, By End User
Table 09: Europe MicroRNA Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2025, By Country
Table 10: Europe MicroRNA Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2025, By Assay Type
Table 11: Europe MicroRNA Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2025, By Applications
Table 12: Europe MicroRNA Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2025, By End User
Table 13: Asia Pacific MicroRNA Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2025, By Country
Table 14: Asia Pacific MicroRNA Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2025, By Assay Type
Table 15: Asia Pacific MicroRNA Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2025, By Applications
Table 16: Asia Pacific MicroRNA Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2025, By End User
Table 17: MEA MicroRNA Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2025, By Country
Table 18: MEA MicroRNA Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2025, By Assay Type
Table 19: MEA MicroRNA Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2025, By Applications
Table 20: MEA MicroRNA Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2025, By End User
Table 21: Global MicroRNA Market Size (US$ Mn) 2012–2016 and Forecast 2017-2025, By Region
Table 22: Global MicroRNA Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2025, By Assay Type
Table 23: Global MicroRNA Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2025, By Applications
Table 24: Global MicroRNA Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2025, By End User